In Licensing, Compound Positioning and Technical Due Diligence
Decode Pharma Partners has a lot of experience and is well renowned for performing compelling and constructive technical due diligence providing thoughtful opinions.
- For Venture capitalist firms and business angels that are looking for investment opportunities
- For biotech and pharmaceutical companies that are looking for in-licensing compounds or patents
- For Tech transfer offices, incubators and companies that are in need for compound repositioning
Decode Pharma Partners multi-disciplinary experts review business and scientific data, including business and financial plan, market and compound positioning, R&D planning and budget, non-clinical, pharmaceutical development (CMC), clinical and regulatory information.
The strengths and weaknesses of the product, the gaps in the development program and the underlying risks are highlighted in a detailed report.
In addition, for young start-up companies that would like to raise funds or out-license their assets Decode Pharma Partners can assist to set-up data room and organise the access to data in the most appropriated way in order to facilitate the due diligence and deal process.